Opportunity Information: Apply for PAR 15 162
Apply for PAR 15 162
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Mar 27, 2015 and posted on Mar 27, 2015.
- Applicants must submit their applications by May 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) County governments Special district governments Public and State controlled institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses For profit organizations other than small businesses State governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21), Funding Opportunity Number PAR-15-162, was a National Institutes of Health (NIH) discretionary grant opportunity designed to back early-stage, small-scale clinical and translational research in urologic disorders. The program used the Exploratory/Developmental Research Grant mechanism (R21), which is typically meant for projects that are promising but not yet ready for a large, definitive clinical study. The core aim was to help investigators generate initial human evidence, practical feasibility data, and early signals of clinical impact that could justify and inform larger follow-on studies.
The scope emphasized pilot and feasibility work in urologic disorders, including clinical and translational studies, epidemiological investigations, and clinical trials. The intent was not to fund full-scale definitive trials right away, but rather to support focused projects that test whether an idea is workable in real-world clinical settings, refine study procedures, validate measures, explore recruitment and retention strategies, or generate preliminary outcome data. NIH highlighted that projects should tackle clinically important questions with the potential for high clinical and public health impact. In other words, the best-fit applications would be those that address meaningful problems in urologic health and can plausibly lead to improved prevention, diagnosis, or treatment strategies once scaled.
A key expectation of the announcement was that some funded projects would serve as a springboard to larger clinical efforts. The FOA specifically anticipated that successful R21 projects could lead to full-scale clinical studies such as expanded diagnostic strategy evaluations, larger epidemiological studies, or randomized clinical trials focused on prevention, diagnosis, or treatment of urologic disorders. This positioning makes the opportunity particularly relevant for teams that have a strong clinical hypothesis or translational concept but need pilot data, proof-of-concept results, or operational feasibility evidence before pursuing a larger R01 or comparable clinical trial mechanism.
From an administrative standpoint, the opportunity was posted on March 27, 2015, with an original and final closing date of May 7, 2018, and it was archived on June 7, 2018. The award ceiling listed was $200,000, and there was no cost-sharing or matching requirement. The listing was associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), reflecting NIH support in areas that include kidney and urologic conditions.
Eligibility was broad and included many types of U.S.-based organizations as well as certain non-U.S. entities. Eligible applicants included public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) organizations), small businesses, for-profit organizations (including those other than small businesses), state, county, and city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The eligibility description also included tribal governments (federally recognized and other than federally recognized) and tribally controlled colleges and universities. Additional eligible applicants explicitly listed included U.S. territory or possession entities, regional organizations, faith-based and community-based organizations, eligible federal agencies, and a range of minority-serving institutions (such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISI institutions). Non-domestic (non-U.S.) entities (foreign organizations) were also included among eligible applicants, indicating NIH openness to international participation where appropriate.
For applicants seeking the full details, NIH provided an additional information link to the program announcement page (http://grants.nih.gov/grants/guide/pa-files/PAR-15-162.html). For technical access issues, the contact point was the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV, including support for problems accessing or linking to the electronic announcement.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21) is a National Institutes of Health (NIH) discretionary funding opportunity (Funding Opportunity Number PAR-15-162) that supported early-stage, small-scale clinical and translational research focused on urologic disorders.
What does "R21" mean in this announcement?
The opportunity used the NIH Exploratory/Developmental Research Grant mechanism (R21). This mechanism is typically intended for promising projects that are not yet ready for a large, definitive clinical study, and that need early human evidence, feasibility data, or initial signals of clinical impact.
What kinds of projects were this FOA meant to support?
The scope emphasized pilot and feasibility work in urologic disorders. The announcement described support for clinical and translational studies, epidemiological investigations, and clinical trials that are appropriate for a small-scale, early-stage R21 project.
Was this program intended to fund full-scale definitive clinical trials?
No. The stated intent was not to fund full-scale definitive trials right away. Instead, it focused on smaller projects designed to test whether an approach is workable, generate preliminary human data, and inform the design of larger follow-on studies.
What types of questions or activities would an R21 pilot project address under this opportunity?
Examples of the kinds of activities emphasized include testing real-world feasibility in clinical settings, refining study procedures, validating measures, exploring recruitment and retention strategies, and generating preliminary outcome data that could justify a larger study.
What was the main goal of the opportunity?
The core aim was to help investigators generate initial human evidence, practical feasibility data, and early signals of clinical impact that could justify and inform larger follow-on studies in urologic disorders.
How did NIH describe the desired impact of supported projects?
NIH highlighted that projects should tackle clinically important questions with the potential for high clinical and public health impact, and that they should plausibly lead to improved prevention, diagnosis, or treatment strategies once scaled.
Was the program designed to help teams move toward larger NIH studies later?
Yes. The announcement anticipated that successful R21 projects could serve as a springboard to full-scale clinical studies, such as expanded diagnostic strategy evaluations, larger epidemiological studies, or randomized clinical trials focused on prevention, diagnosis, or treatment of urologic disorders.
Who would this opportunity have been a good fit for?
It was positioned as especially relevant for teams with a strong clinical hypothesis or translational concept that needed pilot data, proof-of-concept results, or operational feasibility evidence before pursuing a larger study (for example, an R01 or a comparable clinical trial mechanism).
What was the maximum award amount listed?
The award ceiling listed for this opportunity was $200,000.
Was cost-sharing or matching required?
No. The listing stated there was no cost-sharing or matching requirement.
When was this opportunity posted, and what were the closing dates?
The opportunity was posted on March 27, 2015. The original and final closing date listed was May 7, 2018. It was archived on June 7, 2018.
Is this opportunity still open for applications?
No. Based on the provided dates, the final closing date was May 7, 2018, and the opportunity was archived on June 7, 2018.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is PAR-15-162.
What is the CFDA number associated with this opportunity?
The listing was associated with CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), reflecting NIH support in areas that include kidney and urologic conditions.
What types of organizations were eligible to apply?
Eligibility was broad and included many types of U.S.-based organizations as well as certain non-U.S. entities. Eligible applicants included public and private institutions of higher education; nonprofits (including 501(c)(3) and non-501(c)(3)); small businesses; for-profit organizations (including those other than small businesses); state, county, and city or township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities.
Were tribal governments and tribally controlled institutions eligible?
Yes. The eligibility description included tribal governments (federally recognized and other than federally recognized) and tribally controlled colleges and universities.
Were faith-based or community-based organizations eligible?
Yes. Faith-based and community-based organizations were explicitly listed among eligible applicants.
Were U.S. territories or regional organizations eligible?
Yes. The eligibility list explicitly included U.S. territory or possession entities and regional organizations.
Could federal agencies apply?
Yes. Eligible federal agencies were explicitly listed among eligible applicants.
Were minority-serving institutions included in eligibility?
Yes. The eligibility description included a range of minority-serving institutions, such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISI institutions.
Were non-U.S. (foreign) organizations eligible to apply?
Yes. Non-domestic (non-U.S.) entities (foreign organizations) were included among eligible applicants, indicating openness to international participation where appropriate.
Where could applicants find the official program announcement details?
NIH provided an additional information link to the program announcement page at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-162.html
Who should someone contact for technical issues accessing the announcement?
For technical access issues (such as problems accessing or linking to the electronic announcement), the contact point listed was the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Research Answers to NCIs Provocative Questions (R21)
Previous opportunity: Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 162
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 162) also looked into and applied for these:
| Funding Opportunity |
|---|
| New Directions in Hematology Research (SHINE II) (R01) Apply for PAS 15 168 Funding Number: PAS 15 168 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Apply for PA 15 169 Funding Number: PA 15 169 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Pilot and Feasibility Clinical Trials in Diabetes, and Endocrine and Metabolic Diseases (R21) Apply for PA 15 176 Funding Number: PA 15 176 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Interdisciplinary Training in Bioinformatics and Diabetes, Obesity and Metabolic Disease (T32) Apply for PAR 15 182 Funding Number: PAR 15 182 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12) Apply for RFA DK 15 006 Funding Number: RFA DK 15 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Translational Research to Improve Outcomes in Kidney Diseases (R18) Apply for RFA DK 15 009 Funding Number: RFA DK 15 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $225,000 |
| Integrated Food Defense Apply for RFA FD 15 022 Funding Number: RFA FD 15 022 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $100,000 |
| Integrated Food Safety System Online Collaboration Development (U18) Apply for RFA FD 15 024 Funding Number: RFA FD 15 024 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $680,000 |
| FDA Drug Residue Cooperative Agreement Program (U18) Apply for RFA FD 15 025 Funding Number: RFA FD 15 025 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $125,000 |
| Limited Competition Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Apply for RFA FD 15 018 Funding Number: RFA FD 15 018 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $70,000 |
| Implementation of the Animal Feed Regulatory Program Standards (AFRPS) (U18) Apply for RFA FD 15 021 Funding Number: RFA FD 15 021 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $750,000 |
| Food Protection Rapid Response Team (RRT) (U18) Apply for RFA FD 15 020 Funding Number: RFA FD 15 020 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $450,000 |
| Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases (R01) Apply for RFA DK 15 017 Funding Number: RFA DK 15 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $450,000 |
| NIDDK Centers for Diabetes Translation Research (P30) Apply for RFA DK 15 003 Funding Number: RFA DK 15 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding Course Offerings for State and Local Regulators in the Integrated Food Safety System (U18) Apply for RFA FD 15 039 Funding Number: RFA FD 15 039 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| A Community Research Resource of Microbiome Derived Factors Modulating Host Physiology in Obesity, Digestive and Liver Diseases, and Nutrition (R24) Apply for RFA DK 15 012 Funding Number: RFA DK 15 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Exploratory Studies for Delineating Microbiome Host Interactions in Obesity, Digestive and Liver Diseases and Nutrition (R21) Apply for RFA DK 15 013 Funding Number: RFA DK 15 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Exploration of the Roles of Brown and Beige Adipose Tissue in Humans (R01) Apply for RFA DK 15 031 Funding Number: RFA DK 15 031 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding FDAs Produce Safety and Instructor Skills Training under the Food Safety Modernization Act Apply for RFA FD 15 041 Funding Number: RFA FD 15 041 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Mechanisms Underlying the Contribution of Type 1 Diabetes Risk Associated Variants (DP3) Apply for RFA DK 15 025 Funding Number: RFA DK 15 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 162", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.